title: A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor.
authors.affiliation: Daiichi Sankyo Pharma Development, Edison, NJ 08837, USA. jmendell@dsi.com
authors.forename: J
authors.initials: J
authors.lastname: Mendell
authors.forename: R
authors.initials: R
authors.lastname: Basavapathruni
authors.forename: D
authors.initials: D
authors.lastname: Swearingen
authors.forename: A
authors.initials: A
authors.lastname: Draves
authors.forename: G
authors.initials: G
authors.lastname: Zhang
authors.forename: J
authors.initials: J
authors.lastname: Morganroth
mesh_terms: D000293:Adolescent; D000328:Adult; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000009:adverse effects* / Q000032:analysis / Q000493:pharmacokinetics; D004562:Electrocardiography / Q000187:drug effects*; D065427:Factor Xa Inhibitors; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D006207:Half-Life; D006801:Humans; D008297:Male; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D055815:Young Adult
chemical_list: D015507:Drugs, Investigational; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D011725:Pyridines; D013844:Thiazoles; C552171:edoxaban